# MOGAD_meta_2022
 
Reproducibility code for publication: (Efficacy and safety of rituximab in myelin oligodendrocyte glycoprotein antibody-associated disorders compared with neuromyelitis optica spectrum disorder a systematic review and meta-analysis)[http://dx.doi.org/10.1136/jnnp-2022-330086]
